Clinical Trials Sponsored by CTI BioPharma
Total 2446 results
-
CTI BioPharmaCompletedAcute Myelogenous LeukemiaUnited States
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
CTI BioPharmaTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
CTI BioPharmaTerminatedProstate CancerUnited States
-
CTI BioPharmaWithdrawn
-
CTI BioPharmaWithdrawnNon-Hodgkin's LymphomaUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminatedLymphoma, Follicular | Lymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-GradeUnited States
-
CTI BioPharmaCompleted
-
CTI BioPharmaWithdrawnMetastatic CancerUnited States
-
CTI BioPharmaCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post- Essential Thrombocythemia MyelofibrosisUnited States, Spain, United Kingdom, Hungary, Korea, Republic of, France, Italy, Sweden
-
CTI BioPharmaWithdrawnLymphoma | LeukemiaUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminated
-
CTI BioPharmaCompletedLymphoma, Non-HodgkinUnited States, United Kingdom, France, Italy, India, Germany, Hungary, Argentina, Uruguay, Russian Federation, Bulgaria, Costa Rica, Ecuador, Estonia, Mexico, Panama, Peru, Poland, Romania, Ukraine
-
CTI BioPharmaWithdrawnLymphoma | Solid Tumor (Excluding CNS)United States
-
CTI BioPharmaCompletedLymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-Grade | Lymphoma, Small LymphocyticUnited States
-
CTI BioPharmaCompletedOvarian CancerFrance, United Kingdom, Italy
-
CTI BioPharmaCovanceCompletedHealthy SubjectsUnited States
-
CTI BioPharmaCovanceCompleted
-
CTI BioPharmaCovanceCompletedDrug Interaction StudyUnited States
-
CTI BioPharmaPPDRecruiting
-
CTI BioPharmaPPDCompletedDrug InteractionsUnited States
-
CTI BioPharmaCovanceCompleted
-
CTI BioPharmaCovanceCompleted
-
CTI BioPharmaChroma TherapeuticsCompleted
-
CTI BioPharmaQPS-QualitixCompleted
-
CTI BioPharmaPSI CRORecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Canada, Spain, Czechia, United States, Australia, France, Hungary, United Kingdom, Romania, Belarus, Bulgaria, Georgia, Germany, Israel, Italy, Poland, Russian Federation, Serbia, Ukraine, Bosnia and Herzegovina and more
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany, Romania
-
Spectrum Pharmaceuticals, IncCTI BioPharmaTerminatedLymphoma, Follicular | Follicular LymphomaUnited States
-
Northwestern UniversityCTI BioPharma; CephalonUnknownBrain and Central Nervous System TumorsUnited States
-
Stanford UniversityCTI BioPharma; CephalonCompletedBrain CancerUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminated
-
University of Southern CaliforniaCTI BioPharmaWithdrawnBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterCTI BioPharmaCompletedAdvanced Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminatedMyeloproliferative DiseasesUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedMultiple Myeloma | Stem Cell TransplantationUnited States
-
SCRI Development Innovations, LLCCTI BioPharmaCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
SCRI Development Innovations, LLCCTI BioPharmaCompleted
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States